James Leal - 28 Jun 2021 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
SVP, Operations
Signature
s/ David B. Berger, Attorney-in-Fact for James A. Leal
Issuer symbol
TNDM
Transactions as of
28 Jun 2021
Net transactions value
-$18,375
Form type
4
Filing time
30 Jun 2021, 17:47:16 UTC
Previous filing
10 Jun 2021
Next filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $343,350 +6,667 +185% $51.50 10,263 28 Jun 2021 Direct F1
transaction TNDM Common Stock Options Exercise $4,212 +468 +4.6% $9.00 10,731 28 Jun 2021 Direct F1
transaction TNDM Common Stock Sale $713,500 -7,135 -66% $100.00 3,596 28 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Stock Option Options Exercise $343,350 +6,667 +25% $51.50 33,333 28 Jun 2021 Common Stock 6,667 $51.50 Direct F3, F4
transaction TNDM Stock Option Options Exercise $4,212 +468 $9.00 0 28 Jun 2021 Common Stock 468 $9.00 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon exercise of a stock option award.
F2 The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2020.
F3 The options vested as to twenty-five percent (25%) of the underlying shares on 2/15/2020, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
F4 The expiration date for these options is 10 years from the date of grant.
F5 The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.